Last 12 months
Inside the activity.
0 purchase rows · 36 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 17 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2025 Filed Jun 12, 2025 20:27 UTC |
Lambert NicoleDirector
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000086 · wk-form4_1749760070.xml · nonDerivative · entry 1 Lambert Nicole · CIK 0001770252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,300 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
KANEKO YASUNORIDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000087 · wk-form4_1749760080.xml · derivative · entry 5 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
KANEKO YASUNORIDirector
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000087 · wk-form4_1749760080.xml · nonDerivative · entry 1 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,300 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 00:05 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 19,800 | $10.18 | $201,465.00 |
DisclosureSEC source: 0001724521-25-000045 · wk-form4_1740701149.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,554,160 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.13 to $10.185, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 00:06 UTC |
KANEKO YASUNORIDirector
|
PurchaseCommon Stock | 20,000 | $10.06 | $201,200.00 |
DisclosureSEC source: 0001724521-25-000046 · wk-form4_1740701159.xml · nonDerivative · entry 1 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,400 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 18, 2025 Filed Feb 21, 2025 00:42 UTC |
GILEAD SCIENCES, INC.10% owner
|
PurchaseCommon Stock | 1,363,636 | $11.00 | $14,999,996.00 |
DisclosureSEC source: 0001062993-25-003084 · form4.xml · nonDerivative · entry 1 GILEAD SCIENCES, INC. · CIK 0000882095 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,424,760 Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:10 UTC |
Markus RichardChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 305,328 | $0.00 Strike: $12.45 | $0.00 |
DisclosureSEC source: 0001724521-25-000032 · wk-form4_1739326250.xml · derivative · entry 2 Markus Richard · CIK 0002056093 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,328 Underlying: Common Stock · 305,328 shares Expires 2035-01-30 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after February 1, 2025, subject to the Reporting Person's continued service to the Company Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:10 UTC |
Markus RichardChief Medical Officer
|
GrantCommon Stock | 75,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000032 · wk-form4_1739326250.xml · nonDerivative · entry 1 Markus Richard · CIK 0002056093 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,193 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning March 15, 2026, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 16:31 UTC |
Tang Carolyn C.General Counsel
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000021 · wk-form4_1738013456.xml · derivative · entry 2 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 16:31 UTC |
Tang Carolyn C.General Counsel
|
GrantCommon Stock | 37,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000021 · wk-form4_1738013456.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,623 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Ribas AntoniDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000019 · wk-form4_1738013435.xml · derivative · entry 3 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2035-01-22 F1 · derivative.exercise_date: The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 650,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000020 · wk-form4_1738013445.xml · derivative · entry 2 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
GrantCommon Stock | 165,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000020 · wk-form4_1738013445.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,534,360 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Jarrett JenniferChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000018 · wk-form4_1738013425.xml · derivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Jarrett JenniferChief Operating Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000018 · wk-form4_1738013425.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,369 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Goeltz II Robert C.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000017 · wk-form4_1738013415.xml · derivative · entry 2 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2025-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Goeltz II Robert C.Chief Financial Officer
|
GrantCommon Stock | 37,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000017 · wk-form4_1738013415.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,138 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Azoy AlexanderChief Accounting Officer
|
GrantStock Option (right to buy) · Derivative | 11,400 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000016 · wk-form4_1738013405.xml · derivative · entry 2 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,400 Underlying: Common Stock · 11,400 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Azoy AlexanderChief Accounting Officer
|
GrantCommon Stock | 17,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000016 · wk-form4_1738013405.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,194 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:30 UTC |
Lacey David L.Director
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000015 · wk-form4_1738013395.xml · derivative · entry 2 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2035-01-22 F1 · derivative.exercise_date: The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:29 UTC |
Jaen Juan C.President
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001724521-25-000014 · wk-form4_1738013385.xml · derivative · entry 3 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-01-22 F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:29 UTC |
Jaen Juan C.President
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000014 · wk-form4_1738013385.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,220 F1 · shares: Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:08 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 3,594 | $15.00 | $53,910.00 |
DisclosureSEC source: 0001724521-25-000002 · wk-form4_1735938476.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,138 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 21:06 UTC |
Azoy AlexanderChief Accounting Officer
|
Disposition to issuerCommon Stock | 3,007 | $15.17 | $45,616.19 |
DisclosureSEC source: 0001724521-24-000187 · wk-form4_1734728787.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,094 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 20:36 UTC |
Tang Carolyn C.General Counsel
|
Tax withholdingCommon Stock | 11,339 | $16.08 | $182,331.12 |
DisclosureSEC source: 0001724521-24-000183 · wk-form4_1734485805.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,623 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 15, 2024 Filed Dec 18, 2024 01:37 UTC |
Jarrett JenniferChief Operating Officer
|
Tax withholdingCommon Stock | 27,501 | $16.08 | $442,216.08 |
DisclosureSEC source: 0001724521-24-000184 · wk-form4_1734485815.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,369 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 15, 2024 Filed Dec 18, 2024 01:36 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 37,882 | $16.08 | $609,142.56 |
DisclosureSEC source: 0001724521-24-000182 · wk-form4_1734485794.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,369,360 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: This amount reflects 1,547,062 shares of the Issuer's Common Stock that are no longer beneficial owned by the Reporting Person as a result of him entering into a "domestic relations order", which change in beneficial ownership is exempt from Section 16 pursuant to Rule 16a-12 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 15, 2024 Filed Dec 18, 2024 01:36 UTC |
Nuyten Dimitry SAChief Medical Officer
|
Tax withholdingCommon Stock | 7,856 | $16.08 | $126,324.48 |
DisclosureSEC source: 0001724521-24-000181 · wk-form4_1734485783.xml · nonDerivative · entry 1 Nuyten Dimitry SA · CIK 0001776564 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,518 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 15, 2024 Filed Dec 18, 2024 01:36 UTC |
Goeltz II Robert C.Chief Financial Officer
|
Tax withholdingCommon Stock | 10,099 | $16.08 | $162,391.92 |
DisclosureSEC source: 0001724521-24-000180 · wk-form4_1734485773.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,732 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 15, 2024 Filed Dec 18, 2024 01:36 UTC |
Azoy AlexanderChief Accounting Officer
|
Tax withholdingCommon Stock | 2,969 | $16.08 | $47,741.52 |
DisclosureSEC source: 0001724521-24-000179 · wk-form4_1734485761.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,101 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 15, 2024 Filed Dec 18, 2024 01:35 UTC |
Jaen Juan C.President
|
Tax withholdingCommon Stock | 17,286 | $16.08 | $277,958.88 |
DisclosureSEC source: 0001724521-24-000178 · wk-form4_1734485750.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,220 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:10 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 201 | $15.32 | $3,079.32 |
DisclosureSEC source: 0001724521-24-000162 · wk-form4_1733346648.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,070 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024. F2 · shares: Consists of 201 shares purchased on 11/29/2024 through the Company's Employee Stock Purchase Plan. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 22:42 UTC |
Jarrett JenniferChief Operating Officer
|
Tax withholdingCommon Stock | 12,670 | $17.95 | $227,426.50 |
DisclosureSEC source: 0001724521-24-000150 · wk-form4_1726612931.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,394 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 22:42 UTC |
Nuyten Dimitry SAChief Medical Officer
|
Tax withholdingCommon Stock | 5,385 | $17.95 | $96,660.75 |
DisclosureSEC source: 0001724521-24-000149 · wk-form4_1726612922.xml · nonDerivative · entry 1 Nuyten Dimitry SA · CIK 0001776564 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,933 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: Includes 1,123 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 20:45 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 1,357 | $14.97 | $20,314.29 |
DisclosureSEC source: 0001724521-24-000141 · wk-form4_1723754700.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,070 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024. F2 · shares: Consists of 1,357 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 16:53 UTC |
Tang Carolyn C.General Counsel
|
Tax withholdingCommon Stock | 4,182 | $16.97 | $70,968.54 |
DisclosureSEC source: 0001724521-24-000126 · wk-form4_1718744028.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,364 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: Includes 967 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:54 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 12,670 | $16.97 | $215,009.90 |
DisclosureSEC source: 0001724521-24-000129 · wk-form4_1718744059.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,954,304 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:54 UTC |
Jaen Juan C.President
|
Tax withholdingCommon Stock | 6,969 | $16.97 | $118,263.93 |
DisclosureSEC source: 0001724521-24-000128 · wk-form4_1718744048.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,506 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. Read SEC document |
| June 15, 2024 Filed Jun 18, 2024 20:54 UTC |
Jarrett JenniferChief Operating Officer
|
Tax withholdingCommon Stock | 12,670 | $16.97 | $215,009.90 |
DisclosureSEC source: 0001724521-24-000127 · wk-form4_1718744038.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,064 F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2 · balance_after: Includes 481 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:21 UTC |
KANEKO YASUNORIDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001724521-24-000116 · wk-form4_1717798857.xml · derivative · entry 5 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:21 UTC |
KANEKO YASUNORIDirector
|
GrantCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-24-000116 · wk-form4_1717798857.xml · nonDerivative · entry 1 KANEKO YASUNORI · CIK 0001277503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,200 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
Lacey David L.Director
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001724521-24-000115 · wk-form4_1717798846.xml · derivative · entry 2 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
Lacey David L.Director
|
GrantCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-24-000115 · wk-form4_1717798846.xml · nonDerivative · entry 1 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,652 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001724521-24-000114 · wk-form4_1717798835.xml · derivative · entry 3 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
FALBERG KATHRYN EDirector
|
GrantCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-24-000114 · wk-form4_1717798835.xml · nonDerivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,300 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
Machado PatrickDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001724521-24-000113 · wk-form4_1717798823.xml · derivative · entry 2 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
Machado PatrickDirector
|
GrantCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-24-000113 · wk-form4_1717798823.xml · nonDerivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,300 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
PERLMAN ANDREW JDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001724521-24-000112 · wk-form4_1717798812.xml · derivative · entry 2 PERLMAN ANDREW J · CIK 0001201617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
PERLMAN ANDREW JDirector
|
GrantCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-24-000112 · wk-form4_1717798812.xml · nonDerivative · entry 1 PERLMAN ANDREW J · CIK 0001201617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,325 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 22:20 UTC |
Ribas AntoniDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001724521-24-000111 · wk-form4_1717798800.xml · derivative · entry 3 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.